Alternative mechanisms for trafficking of lysosomal enzymes in mannose 6-phosphate receptor-deficient mice are cell type-specific F Dittmer, EJ Ulbrich, A Hafner, W Schmahl, T Meister, R Pohlmann, ... Journal of cell science 112 (10), 1591-1597, 2000 | 149 | 2000 |
Monocyte chemoattractant protein-1 serum levels in patients with breast cancer A Lebrecht, C Grimm, T Lantzsch, E Ludwig, L Hefler, E Ulbrich, H Koelbl Tumor Biology 25 (1-2), 14-17, 2004 | 142 | 2004 |
Breast cancer survival in sub‐Saharan Africa by age, stage at diagnosis and human development index: A population‐based registry study WY Joko‐Fru, A Miranda‐Filho, I Soerjomataram, M Egue, ... International journal of cancer 146 (5), 1208-1218, 2020 | 138 | 2020 |
Breast cancer survival in Ethiopia: a cohort study of 1,070 women EJ Kantelhardt, P Zerche, A Mathewos, P Trocchi, A Addissie, A Aynalem, ... International journal of cancer 135 (3), 702-709, 2014 | 133 | 2014 |
Validation of the Patient Health Questionnaire (PHQ-9) as a screening tool for depression in pregnant women: Afaan Oromo version YK Woldetensay, T Belachew, M Tesfaye, K Spielman, HK Biesalski, ... PloS one 13 (2), e0191782, 2018 | 120 | 2018 |
Estrogen‐metabolizing gene polymorphisms in the assessment of breast carcinoma risk and fibroadenoma risk in Caucasian women LA Hefler, CB Tempfer, C Grimm, A Lebrecht, E Ulbrich, G Heinze, ... Cancer 101 (2), 264-269, 2004 | 112 | 2004 |
Mutant p53 promotes tumor progression and metastasis by the endoplasmic reticulum UDPase ENTPD5 F Vogiatzi, DT Brandt, J Schneikert, J Fuchs, K Grikscheit, M Wanzel, ... Proceedings of the National Academy of Sciences 113 (52), E8433-E8442, 2016 | 111 | 2016 |
Cancer therapy trials employing level-of-evidence-1 disease forecast cancer biomarkers uPA and its inhibitor PAI-1 M Schmitt, N Harbeck, N Brünner, F Jänicke, C Meisner, B Mühlenweg, ... Expert review of molecular diagnostics 11 (6), 617-634, 2011 | 106 | 2011 |
Cervical cancer screening knowledge and barriers among women in Addis Ababa, Ethiopia S Getachew, E Getachew, M Gizaw, W Ayele, A Addissie, EJ Kantelhardt PloS one 14 (5), e0216522, 2019 | 102 | 2019 |
Moderate HER2 expression as a prognostic factor in hormone receptor positive breast cancer. H Eggemann, T Ignatov, E Burger, EJ Kantelhardt, F Fettke, C Thomssen, ... Endocrine-related cancer 22 (5), 725-733, 2015 | 98 | 2015 |
Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy EJ Kantelhardt, U Moelle, M Begoihn, A Addissie, P Trocchi, B Yonas, ... The oncologist 19 (7), 727-734, 2014 | 90 | 2014 |
First data from a population based cancer registry in Ethiopia G Timotewos, A Solomon, A Mathewos, A Addissie, S Bogale, ... Cancer epidemiology 53, 93-98, 2018 | 89 | 2018 |
Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors S Bernhardt, M Bayerlová, M Vetter, A Wachter, D Mitra, V Hanf, ... Breast Cancer Research 19, 1-14, 2017 | 88 | 2017 |
Quality of life of cancer patients at palliative care units in developing countries: systematic review of the published literature D Gayatri, L Efremov, EJ Kantelhardt, R Mikolajczyk Quality of Life Research 30, 315-343, 2021 | 84 | 2021 |
Cervical cancer survival in sub‐Saharan Africa by age, stage at diagnosis and Human Development Index: A population‐based registry study M Sengayi‐Muchengeti, WY Joko‐Fru, A Miranda‐Filho, M Egue, ... International journal of cancer 147 (11), 3037-3048, 2020 | 84 | 2020 |
COVID-19 and the public response: Knowledge, attitude and practice of the public in mitigating the pandemic in Addis Ababa, Ethiopia Z Desalegn, N Deyessa, B Teka, W Shiferaw, D Hailemariam, A Addissie, ... PloS one 16 (1), e0244780, 2021 | 83 | 2021 |
Cancer in Africa 2018: The role of infections DM Parkin, L Hämmerl, J Ferlay, EJ Kantelhardt International journal of cancer 146 (8), 2089-2103, 2020 | 82 | 2020 |
A review on breast cancer care in Africa EJ Kantelhardt, G Muluken, G Sefonias, A Wondimu, HC Gebert, ... Breast Care 10 (6), 364-370, 2015 | 75 | 2015 |
Highly sensitive profiling of CD44+/CD24− breast cancer stem cells by combining global mRNA amplification and next generation sequencing: evidence for a hyperactive PI3K pathway O Hardt, S Wild, I Oerlecke, K Hofmann, S Luo, Y Wiencek, E Kantelhardt, ... Cancer letters 325 (2), 165-174, 2012 | 73 | 2012 |
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6× FEC versus 3× FEC/3 … EJ Kantelhardt, M Vetter, M Schmidt, C Veyret, D Augustin, V Hanf, ... BMC cancer 11, 1-10, 2011 | 72 | 2011 |